A population pharmacokinetic and pharmacokinetic‐pharmacodynamic analysis of vupanorsen from phase I and phase II studies

Vupanorsen (PF‐07285557) is a second‐generation ligand‐conjugated 2′O‐methoxyethyl modified antisense oligonucleotide designed to target angiopoietin‐like 3 (ANGPTL3) mRNA expressed by the liver, shown to reduce lipids and apolipoproteins in subjects with dyslipidemia. Using pooled data from two pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahn, Jae Eun, Terra, Steven G., Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349191/
https://www.ncbi.nlm.nih.gov/pubmed/37170423
http://dx.doi.org/10.1002/psp4.12969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349191/
https://www.ncbi.nlm.nih.gov/pubmed/37170423
http://dx.doi.org/10.1002/psp4.12969

Ejemplares similares